ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,769.00
0.41%
S&P ASX All Technology
3,068.30
0.93%
Brent Oil
77.585
0.62%
US Dollar vs AUD
1.504
-0.05%
Bitcoin
70,910.49
0.40%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Ipsen SA (IPN)

  7. Ipsen SA (IPN) News

IPN

Ipsen (IPN)

Ipsen SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:IPN
DateTimeSourceHeadlineSymbolCompany
05/06/202416:00GlobeNewswire Inc.Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis    EU:IPNIpsen SA
03/06/202415:00GlobeNewswire Inc.Ipsen lance un programme de rachat d’actions pour couvrir son programme d’attribution d’actions gratuites aux salariésEU:IPNIpsen SA
03/06/202415:00GlobeNewswire Inc.Ipsen initiates a share buy-back program to cover its free employee share-allocation planEU:IPNIpsen SA
31/05/202402:15GlobeNewswire Inc.Ipsen annonce le lancement d'une opération d’actionnariat salariéEU:IPNIpsen SA
31/05/202402:15GlobeNewswire Inc.Ipsen announces the launch of an employee shareholding planEU:IPNIpsen SA
29/05/202402:00GlobeNewswire Inc.Annual General Meeting of Ipsen S.A. held on 28 May 2024EU:IPNIpsen SA
29/05/202402:00GlobeNewswire Inc.Assemblée Générale Annuelle d’Ipsen S.A. du 28 mai 2024EU:IPNIpsen SA
28/05/202415:00GlobeNewswire Inc.Descriptif du cadre réglementaire du programme de rachat d’actions soumis par le Conseil d’administration à l’approbation de l’Assemblée Générale Annuelle des actionnaires d’Ipsen S.A. du 28 mai 2024EU:IPNIpsen SA
28/05/202415:00GlobeNewswire Inc.Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.’s Annual General Meeting on 28 May 2024EU:IPNIpsen SA
07/05/202422:55GlobeNewswire Inc.Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General MeetingEU:IPNIpsen SA
07/05/202422:55GlobeNewswire Inc.IPSEN SA. - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale Mixte du 28 mai 2024EU:IPNIpsen SA
07/05/202402:00GlobeNewswire Inc.Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capitalEU:IPNIpsen SA
07/05/202402:00GlobeNewswire Inc.Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialEU:IPNIpsen SA
02/05/202415:30GlobeNewswire Inc.Ipsen nomme Keira Driansky, en qualité de Vice-Présidente Exécutive, et Présidente Amérique du NordEU:IPNIpsen SA
02/05/202415:30GlobeNewswire Inc.Ipsen appoints Keira Driansky as EVP, President of North AmericaEU:IPNIpsen SA
02/05/202415:30GlobeNewswire Inc.Ipsen appoints Keira Driansky as EVP, President of North AmericaEU:IPNIpsen SA
24/04/202415:00GlobeNewswire Inc.Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceEU:IPNIpsen SA
24/04/202415:00GlobeNewswire Inc.Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceEU:IPNIpsen SA
24/04/202415:00GlobeNewswire Inc.Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024EU:IPNIpsen SA
22/04/202415:00GlobeNewswire Inc.Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesEU:IPNIpsen SA
22/04/202415:00GlobeNewswire Inc.Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesEU:IPNIpsen SA
22/04/202415:00GlobeNewswire Inc.Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques raresEU:IPNIpsen SA
18/04/202402:00GlobeNewswire Inc.Ipsen publishes its 2023 Universal Registration DocumentEU:IPNIpsen SA
18/04/202402:00GlobeNewswire Inc.Ipsen publie son Document d’enregistrement universel 2023EU:IPNIpsen SA
09/04/202402:00GlobeNewswire Inc.Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialEU:IPNIpsen SA
09/04/202402:00GlobeNewswire Inc.Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capitalEU:IPNIpsen SA
02/04/202416:00GlobeNewswire Inc.Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumorsEU:IPNIpsen SA
02/04/202416:00GlobeNewswire Inc.Ipsen et Sutro Biopharma annoncent la signature d'un accord exclusif de licence mondiale pour un conjugué anticorps-petite molecule ciblant les tumeurs solidesEU:IPNIpsen SA
02/04/202416:00GlobeNewswire Inc.Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumorsEU:IPNIpsen SA
08/03/202404:00GlobeNewswire Inc.Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialEU:IPNIpsen SA
 Showing the most relevant articles for your search:EU:IPN

Your Recent History

EU
ENX
Euronext NV
EU
NHWNR
Euronext NDR Hydrogen Wo...
AMEX
DEM
WisdomTree Emerging Mark...
TG
IPT
International Petroleum
EU
FR0127269514
CA Consumer Finance Cacf...
LSE
SESP
Satsusesghanacc
NYSE
GJF
Synthetic FD IN 6.75
EU
FGING
EN Top 30 France Germany...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved